Platinum Investment Mangement »

4d Molecular Therapeutics In shares owned by Platinum Investment Mangement

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Platinum Investment Mangement from 13F filings

Historical chart of Platinum Investment Mangement investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Platinum Investment Mangement consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Platinum Investment Mangement

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 41k 31.86

More positions owned by Platinum Investment Mangement

Zto Express Cayman Sponsored Ads A (ZTO)
Micron Technology (MU)
Intercontinental Exchange (ICE)
Transunion (TRU)
Broadcom (AVGO)
Trip Com Group Ads (TCOM)
Microchip Technology (MCHP)
Cameco Corporation (CCJ)
Schlumberger Com Stk (SLB)
Meta Platforms Cl A (META)
Valaris Cl A (VAL)
Baxter International (BAX)
Alphabet Cap Stk Cl C (GOOG)
Pdd Holdings Sponsored Ads (PDD)
Alibaba Group Hldg Sponsored Ads (BABA)

View all positions for Platinum Investment Mangement

Top funds holding 4d Molecular Therapeutics In

RA Capital Management
VR Adviser
BlackRock
BVF
Henderson Group
Goldman Sachs Group
Viking Global Investors
Vanguard Group
Morgan Stanley
Redmile Group
Arrowpoint Asset Management
Braidwell
FMR
Geode Capital Management
Casdin Capital

View all funds holding 4d Molecular Therapeutics In